These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 762792)

  • 1. Indomethacin and the nephrotic syndrome.
    Shehadeh IH; Demers LM; Abt AB; Schoolwerth AC
    JAMA; 1979 Mar; 241(12):1264-6. PubMed ID: 762792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of proteinuria by indomethacin in patients with nephrotic syndrome.
    Alavi N; Lianos EA; Venuto RC; Mookerjee BK; Bentzel CJ
    Am J Kidney Dis; 1986 Dec; 8(6):397-403. PubMed ID: 3468803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the nephrotic syndrome with indomethacin.
    Donker AJ; Brentjens JR; van der Hem GK; Arisz L
    Nephron; 1978; 22(4-6):374-81. PubMed ID: 740100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome.
    Arisz L; Donker AJ; Brentjens JR; van der Hem GK
    Acta Med Scand; 1976; 199(1-2):121-5. PubMed ID: 1251764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
    Vriesendorp R; de Zeeuw D; de Jong PE; Donker AJ; Pratt JJ; van der Hem GK
    Clin Nephrol; 1986 Feb; 25(2):105-10. PubMed ID: 3516475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of adjuvant arthritis on main urinary metabolites of prostaglandin F and E in rats.
    Honda H; Fukawa K; Sawabe T
    Prostaglandins; 1980 Feb; 19(2):259-69. PubMed ID: 7384541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy.
    Espinoza LR; Jara LJ; Martinez-Osuna P; Silveira LH; Cuellar ML; Seleznick M
    Lupus; 1993 Feb; 2(1):9-14. PubMed ID: 8485564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indomethacin on proteinuria in rats with autologous immune complex nephropathy.
    Kirschenbaum MA; Liebross BA; Serros ER
    Prostaglandins; 1985 Aug; 30(2):295-303. PubMed ID: 2931744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of prostaglandin E and F 2 alpha in healthy newborn infants and in infants with hyaline membrane disease.
    Csaba IF; Sulyok E; Ertl T
    Acta Paediatr Acad Sci Hung; 1979; 20(2-3):193-8. PubMed ID: 546017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian and plasma PGE and PGF levels in naturally ovulating brook trout (Salvelinus fontinalis) and the effects of indomethacin on prostaglandin levels.
    Goetz FW; Cetta F
    Prostaglandins; 1983 Sep; 26(3):387-95. PubMed ID: 6658000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal prostaglandin excretion in children with minimal change nephrotic syndrome.
    Januszewicz P; Ignatowska-Switalska H; Wyszyńska T
    Prostaglandins Med; 1981 Aug; 7(2):149-55. PubMed ID: 6944704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of indomethacin on active and inactive renin in sodium-replete men at rest and during exercise.
    Lijnen P; Groeseneken D; Fagard R; Staessen J; Amery A
    J Lab Clin Med; 1984 May; 103(5):677-83. PubMed ID: 6425442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostaglandin E2 and F2 alpha excretion in nephrotic syndrome during basal conditions, after water loading, and after remission of the syndrome.
    Pedersen EB; Christensen P; Danielsen H; Eiskjaer H; Jespersen B; Leyssac PP; Sørensen SS
    Acta Med Scand; 1988; 224(1):69-77. PubMed ID: 3166326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin suppression: inability to correct severe idiopathic orthostatic hypotension.
    Crook JE; Robertson D; Whorton AR
    South Med J; 1981 Mar; 74(3):318-20. PubMed ID: 7013082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome.
    Garin EH; Williams RL; Fennell RS; Richard GA
    J Pediatr; 1978 Jul; 93(1):138-40. PubMed ID: 650326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double isotope derivative dilution method for the determination of prostaglandin F and E type metabolites in urine.
    Aizawa Y; Yamada K; Hata M
    Prostaglandins; 1977; 14(6):1165-74. PubMed ID: 341230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary prostaglandin E excretion: effect of chronic alterations in sodium intake and inhibition of prostaglandin synthesis in the rabbit.
    Lifschitz MD; Patak RV; Fadem SZ; Stein JH
    Prostaglandins; 1978 Oct; 16(4):607-19. PubMed ID: 725091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.